|
|
Multiple sclerosis: current and prospective therapies
Interferon-beta-1a: therapeutic effects, tolerability, current and future status in multiple sclerosis
Per Soelberg Sørensen
Correspondence to:
Per Soelberg Sørensen - MD, DMSci Professor in Neurology Danish Multiple Sclerosis Research Center Department of Neurology University of Copenhagen Copenhagen University Hospital, Rigshospitalet Copenhagen, Denmark E-mail: pss@rh.dk
[346 Kb]
|
|